MedPath

KOCHI UNIVERSITY

πŸ‡―πŸ‡΅Japan
Ownership
-
Employees
-
Market Cap
-
Website

Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?

Completed
Conditions
Pancreatic Cancer Metastatic
Interventions
Drug: chemotherapy agents
First Posted Date
2025-04-10
Last Posted Date
2025-04-10
Lead Sponsor
Kochi University
Target Recruit Count
276
Registration Number
NCT06921252

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Completed
Conditions
Pancreatic Cancer Resectable
First Posted Date
2025-02-05
Last Posted Date
2025-02-05
Lead Sponsor
Kochi University
Target Recruit Count
100
Registration Number
NCT06809374

Preoperative Edema is a Significant Risk Factor for Post-hepatectomy Complications

Completed
Conditions
Patients Who Underwent Hepatectomy for Liver Neoplasms
First Posted Date
2024-08-15
Last Posted Date
2024-08-15
Lead Sponsor
Kochi University
Target Recruit Count
414
Registration Number
NCT06555510
Locations
πŸ‡―πŸ‡΅

Takehiro Okabayashi, Kochi, Japan

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP

Phase 2
Recruiting
Conditions
Pancreatic Adenocarcinoma
Interventions
Drug: GS
First Posted Date
2022-03-07
Last Posted Date
2022-03-07
Lead Sponsor
Kochi University
Target Recruit Count
500
Registration Number
NCT05268692
Locations
πŸ‡―πŸ‡΅

Takehiro Okabayashi, Kochi, Japan

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

Recruiting
Conditions
Cancer
First Posted Date
2022-02-25
Last Posted Date
2022-02-25
Lead Sponsor
Kochi University
Target Recruit Count
1000
Registration Number
NCT05257434
Locations
πŸ‡―πŸ‡΅

Takehiro Okabayashi, Kochi, Japan

Both Short- and Long-term Outcome Differences According to Patient Frailty

Recruiting
Conditions
Frailty
First Posted Date
2022-02-25
Last Posted Date
2022-02-25
Lead Sponsor
Kochi University
Target Recruit Count
1000
Registration Number
NCT05257226
Locations
πŸ‡―πŸ‡΅

Takehiro Okabayashi, Kochi, Japan

L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients

Phase 2
Conditions
Ammonia Metabolism
Interventions
Other: usual intake
First Posted Date
2017-01-16
Last Posted Date
2017-01-16
Lead Sponsor
Kochi University
Target Recruit Count
80
Registration Number
NCT03021876
Locations
πŸ‡―πŸ‡΅

Kochi Health Sciences Center, Kochi, Japan

Accuracy and Reliability of GSA for Remnant Liver Function

Conditions
Both Benign and Malignant Liver Mass
First Posted Date
2013-12-17
Last Posted Date
2013-12-17
Lead Sponsor
Kochi University
Registration Number
NCT02013895
Locations
πŸ‡―πŸ‡΅

Kochi Health Sciences Center, Kochi, Japan

Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids

Not Applicable
Completed
Conditions
Liver Cancer
Interventions
Drug: LIVACT
First Posted Date
2011-09-15
Last Posted Date
2011-09-15
Lead Sponsor
Kochi University
Target Recruit Count
56
Registration Number
NCT01434524
Locations
πŸ‡―πŸ‡΅

Kochi Medical School, Nankoku, Kochi, Japan

STA-21 Topical Efficacy on Psoriasis

Phase 1
Completed
Conditions
Psoriasis
Interventions
Drug: Topical application of STA-21 ointment for treatment of psoriasis
First Posted Date
2010-01-13
Last Posted Date
2010-01-13
Lead Sponsor
Kochi University
Target Recruit Count
8
Registration Number
NCT01047943
Locations
πŸ‡―πŸ‡΅

Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan

Β© Copyright 2025. All Rights Reserved by MedPath